Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zhuhai Meihua Medical Technology

Request full access

Provides information and intelligence services for corporate marketing departments

ChinaFounded 2007Marketing

About Zhuhai Meihua Medical Technology

Zhuhai Meihua Medical Technology Co., Ltd., established in 2007, is a high-tech enterprise specializing in the field of in-vitro diagnostic (IVD) instruments and reagents. Initially the liquid-based product division of Shanghai Angbai Biomedical Technology Co., Ltd., the company now operates as a wholly-owned subsidiary. The firm is focused on providing comprehensive solutions for clinical microbiology laboratories. Its business strategy centers on developing products with independent intellectual property rights to achieve both "technical substitution" and "import substitution" within the Chinese market.

The company's clientele includes thousands of hospitals, laboratories, and scientific research institutions. Its products are distributed in over 40 countries and regions, demonstrating a significant international footprint. The business model involves the research and development, manufacturing, sales, and service of its diagnostic systems and consumables. Meihua has received venture capital backing, including a Series B funding round of $13.9 million in November 2022.

Meihua's product portfolio is extensive, featuring over 30 types of in-vitro diagnostic instruments and reagents across six main series. A cornerstone of their offering is the MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) microbial mass spectrometry system for rapid microorganism identification. Other key products include automated microbial identification and antibiotic susceptibility testing (ID/AST) systems, automatic blood culture analysis systems, and a range of microbiological culture media and laboratory automation equipment. These systems are designed to provide rapid, accurate, and cost-effective detection of a wide array of microorganisms, such as bacteria and fungi, to aid in the clinical diagnosis of conditions like bloodstream infections.

The company's research and development team is composed of scientists and clinical doctors from international institutions, including the Mayo Medical Center and Yale University School of Medicine. This has enabled the company to secure over 40 patents and receive numerous accolades for its products, with 22 being recognized as "Guangdong High-tech Products". The firm's stated mission is to become a distinguished global brand in the testing field by providing precise, comprehensive solutions for microbial detection.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
18.0/100
Industry
Marketing
Business model
SaaS
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Dec 2022 $14M $55M Sunland fund · Zhuhai High-tech Gold Investment · Humble Capital · Eight Roads Ventures ↗
ANGELEquity / VC Sep 2007 $399K $1.6M Biochem Group · Oriental Fortune Capital · TEDA Venture Capital —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Zhuhai Meihua Medical Technology website traffic

Latest recorded traffic for Zhuhai Meihua Medical Technology is 410 monthly website visits, down 43.1% over the last three months.

Latest monthly visits410 3-month web change-43.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Zhuhai Meihua Medical Technology in its local ecosystem

Live from Dealroom

The Zhuhai Meihua Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Biochem Group
  • Oriental Fortune Capital
  • TEDA Venture Capital

Series A4 investors entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Zhuhai Meihua Medical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zhuhai Meihua Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.